-

The IMA Group Announces Leadership Appointment in Clinical Research Division

Industry Veteran Dana Poff Joins Rapidly Expanding Team

TARRYTOWN, N.Y.--(BUSINESS WIRE)--The IMA Group (IMA), a leading technology-enabled provider of clinical trials and medical and psychological screening and evaluation services, announced today that industry veteran Dana Poff would lead IMA’s Clinical Research Division as Executive Vice President. IMA Clinical Research is a flexible, full-service clinical trial network consisting of geographically diverse clinical trial sites and over 150 satellite sites that conduct site-based, hybrid and decentralized clinical trials.

Poff, a high-profile leader in the clinical trial space, brings over 30 years of clinical trial experience to IMA, having held senior level positions overseeing global project management, strategic alliances and clinical operations for ICON, plc.

“I’m excited to join the team at IMA Clinical Research,” said Poff. “Together, we’ll continue with the impressive growth and scale of the company's unique delivery model. By leveraging dedicated sites, staff, physicians, and clinics, we can help facilitate the advancement of drug development and bring innovative treatments to patients.”

Dr. Mark Weinberger, President and CEO of the IMA Group, stated, “We are incredibly pleased to have Dana lead our clinical research division. Her world-class experience conducting clinical trials will accelerate the substantial growth and expansion in footprint and diversity our clinical research division has enjoyed over the last several years.”

The company also reported that Michael Minor, who has played a vital role in fueling the growth of the division, will remain as an Executive Advisor to the IMA Group’s highly experienced clinical research team (https://imaresearch.com/about/leadership/).

About The IMA Group

The IMA Group is a leading technology-enabled provider of clinical trial and medical and psychological screening and evaluation services. IMA Clinical Research, a division of The IMA Group, is a physician-founded network of comprehensive clinical research sites specializing in Phase II-IV clinical trials in multiple therapeutic areas. IMA Clinical Research conducts site-based, hybrid and fully decentralized clinical trials that support the development of safe and effective new treatments. For more information, visit https://imaresearch.com/ or https://theimagroup.com/.

Contacts

Brenna Harrington
Scott Public Relations
706-217-7809

The IMA Group LogoThe IMA Group Logo

The IMA Group


Release Summary
With more than 30 years experience in clinical trials, industry leader Dana Poff joins the IMA Group's growing Clinical Research Division as EVP.
Release Versions

Contacts

Brenna Harrington
Scott Public Relations
706-217-7809

Social Media Profiles
More News From The IMA Group

Sales Exec. Sara Mulick Joins The IMA Group as Senior Vice President of Sales

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Sara Mulick, a seasoned workers' compensation sales executive with over two decades of industry expertise, has been named Senior Vice President of Sales at The IMA Group (IMA). In her new capacity, she will spearhead the expansion of the company's Evaluation Services division. The division provides workers' compensation, liability, and disability independent medical exams (IME), case management services, fitness for duty/pre-employment evaluations, medical/psyc...

The IMA Group Announces Acquisition of Pontum Health

TARRYTOWN, N.Y.--(BUSINESS WIRE)--The IMA Group has announced its acquisition of Pontum Health, adding two key new states and strengthening its evaluation services in the Northwest....

The IMA Group Acquires Accelemed Research Institute

TARRYTOWN, N.Y.--(BUSINESS WIRE)--The IMA Group has acquired Accelemed Research Institute in Austin, TX expanding its presence in the Southwest and clinical trial capabilities....
Back to Newsroom